ADJUVANT HORMONE-THERAPY IN BREAST-CANCER

被引：2

作者：

BLOMQVIST, CP

ELOMAA, I

RISSANEN, P

机构：

[1] Department of Radiotherapy and Oncology, Helsinki University Central Hospital, Helsinki

来源：

ANNALS OF MEDICINE | 1992年 / 24卷 / 02期

关键词：

BREAST CANCER; ADJUVANT THERAPY; TAMOXFEN; OOPHORECTOMY;

D O I：

10.3109/07853899209148333

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent results from controlled trials of adjuvant tamoxifen and oophorectomy in early breast cancer are reviewed. The results of the statistical overview performed by the Early Breast Cancer Trialists Collaborative Group are summarised, and some important questions left open by this overview are discussed. These include the choice of patients for adjuvant endocrine treatment, long term results of tamoxifen, interaction with postoperative radiotherapy, the effect of tamoxifen on non-cancer deaths, and interaction of the adjuvant effect of tamoxifen with concentrations of oestrogen receptor levels in the tumour.

引用

收藏

页码：91 / 96

页数：6

相关论文

共 26 条

[1] EFFECTS OF TAMOXIFEN TREATMENT ON PLASMA-LIPIDS AND LIPOPROTEIN LIPID-COMPOSITION [J].

BAGDADE, JD ;

WOLTER, J ;

SUBBAIAH, PV ;

RYAN, W .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :1132-1135

[2] ADJUVANT TAMOXIFEN IN PRIMARY BREAST-CANCER - INFLUENCE ON PLASMA-LIPIDS AND ANTITHROMBIN-III LEVELS [J].

BERTELLI, G ;

PRONZATO, P ;

AMOROSO, D ;

CUSIMANO, MP ;

CONTE, PF ;

MONTAGNA, G ;

BERTOLINI, S ;

ROSSO, R .

BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (03) :307-310

[3] TAMOXIFEN, SERUM-LIPOPROTEINS AND CARDIOVASCULAR RISK [J].

BRUNING, PF ;

BONFRER, JMG ;

HART, AAM ;

DEJONGBAKKER, M ;

LINDERS, D ;

VANLOON, J ;

NOOYEN, WJ .

BRITISH JOURNAL OF CANCER, 1988, 58 (04) :497-499

[4] BREAST-CANCER THERAPY - EXERCISING ALL OUR OPTIONS [J].

DEVITA, VT .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :527-529

[5]

EBCTC Group, 1992, LANCET, V339, P1

[6] BONE-MINERAL CONTENT OF WOMEN RECEIVING TAMOXIFEN FOR MASTALGIA [J].

FENTIMAN, IS ;

CALEFFI, M ;

RODIN, A ;

MURBY, B ;

FOGELMAN, I .

BRITISH JOURNAL OF CANCER, 1989, 60 (02) :262-264

[7] A RANDOMIZED CLINICAL-TRIAL EVALUATING TAMOXIFEN IN THE TREATMENT OF PATIENTS WITH NODE-NEGATIVE BREAST-CANCER WHO HAVE ESTROGEN-RECEPTOR POSITIVE TUMORS [J].

FISHER, B ;

COSTANTINO, J ;

REDMOND, C ;

POISSON, R ;

BOWMAN, D ;

COUTURE, J ;

DIMITROV, NV ;

WOLMARK, N ;

WICKERHAM, DL ;

FISHER, ER ;

MARGOLESE, R ;

ROBIDOUX, A ;

SHIBATA, H ;

TERZ, J ;

PATERSON, AHG ;

FELDMAN, MI ;

FARRAR, W ;

EVANS, J ;

LICKLEY, HL ;

KETNER, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08) :479-484

[8]

FORNANDER T, 1989, LANCET, V1, P117

[9] LONG-TERM ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER - EFFECT ON BONE-MINERAL DENSITY IN POSTMENOPAUSAL WOMEN [J].

FORNANDER, T ;

RUTQVIST, LE ;

SJOBERG, HE ;

BLOMQVIST, L ;

MATTSSON, A ;

GLAS, U .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :1019-1024

[10]

GOLDHIRSCH A, 1986, NCI MONOGRAPHS, V1, P55